Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Exchange Act during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provide pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: Common stock .01 par value as of ~~November 18, 2019: 14,764,587 shares.~~

	September 30, 2019			December 31, 2018			March 31, 2020			December 31, 2019
Assets	(Unaudited)						(Unaudited)
Available-for-sale fixed maturity securities at fair value (Amortized cost: $8,106,196 and $6,828,467 as of September 30, 2019 and December 31, 2018, respectively)	$	8,596,701		$	6,665,056
Available-for-sale fixed maturity securities at fair value (Amortized cost: $8,780,402 and $7,673,671 as of March 31, 2020 and December 31, 2019, respectively)							$	8,627,851		$	8,089,460
Mortgage loans		2,473,673			1,445,030			2,464,706			2,908,541
Other long-term investments		2,076,262			449,461			2,839,318			1,966,347
Total investments		13,146,636			8,559,547			13,931,875			12,964,348
Cash and cash equivalents		11,327,582			6,511,652			17,845,572			15,208,477
Accrued investment income		104,378			76,668			139,581			111,889
Due premium		8,416			5,050			18,525			5,075
Deferred policy acquisition costs		576,268			326,210			779,664			668,454
Deferred sales inducement costs		649,667			164,316			953,361			770,177
Advances and notes receivable		102,987			14,360			176,821			134,560
Leased property - right to use		276,703			-			227,607			248,298
Federal and state income taxes recoverable								89,882			71,839
Security deposit		7,109			7,109			7,109			7,109
Prepaid and other assets		85,224			33,871			102,239			68,500
Furniture and equipment, net		29,991			34,210			23,923			26,840
Total assets	$	26,314,961		$	15,732,993		$	34,296,159		$	30,285,566

Liabilities and Shareholders’ Equity
Policy liabilities
Policyholders’ account balances	$	13,802,901		$	3,165,519		$	23,497,676		$	18,440,872
Future policy benefits		480,254			338,407			573,247			516,870
Policy claims and other benefits		46,083			28,306			62,114			59,693
Liability for deposit-type contracts		14,760			19,540			9,838			14,870
Other policyholder liabilities		247,428			9,283			270,656			160,000
Total policy liabilities		14,591,426			3,561,055			24,413,531			19,192,305
Lease liability		276,703			-			227,607			248,298
Deferred taxes		49,081			-			-			87,104
Accounts payable		70,938			143,065			115,287			85,044
Total liabilities		14,988,148			3,704,120			24,756,425			19,612,751

Shareholders’ equity
Common stock, par value $.01 per share, 25,000,000 shares authorized, 14,867,097 issued as of September 30, 2019 and December 31, 2018, 14,801,587 and 14,850,097 outstanding as of September 30, 2019 and December 31, 2018, respectively		148,671			148,671
Common stock, par value $.01 per share, 25,000,000 shares authorized, 14,867,097 issued as of March 31, 2020 and December 31, 2019, 14,764,587 outstanding as of March 31, 2020 and December 31, 2019.								148,671			148,671
Additional paid-in capital		17,538,618			17,538,618			17,538,618			17,538,618
Treasury stock, at cost (65,510 and 17,000 shares as of September 30, 2019 and December 31, 2018, respectively)		(81,175	)		(50,000	)
Treasury stock, at cost (102,510 shares as of March 31, 2020 and December 31, 2019)								(104,485	)		(104,485	)
Accumulated other comprehensive income (loss)		440,483			(162,781	)		(152,156	)		327,676
Accumulated deficit		(6,719,784	)		(5,445,635	)		(7,890,914	)		(7,237,665	)
Total shareholders’ equity		11,326,813			12,028,873			9,539,734			10,672,815
Total liabilities and shareholders’ equity	$	26,314,961		$	15,732,993		$	34,296,159		$	30,285,566

	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,
	2019			2018			2019			2018			2020			2019
Revenues
Premiums and other considerations	$	52,080		$	77,341		$	303,002		$	313,098
Premiums income													$	119,145		$	118,392
Net investment income		202,907			113,966			513,125			249,848			216,976			136,571
Commission income		31,694			12,674			114,550			53,236			8,253			3,533
Total revenues		286,681			203,981			930,677			616,182			344,374			258,496
Benefits, claims and expenses
Increase in future policy benefits		16,718			28,159			141,496			152,419			56,384			59,349
Death and other benefits		9,591			8,204			17,777			14,134			2,421			2,239
Interest credited to policyholders		81,484			15,147			173,017			47,059			206,151			26,032
Total benefits and claims		107,793			51,510			332,290			213,612			264,956			87,620
Policy acquisition costs deferred		(115,949	)		(42,102	)		(305,757	)		(188,220	)		(135,177	)		(91,949	)
Policy acquisition costs amortized		15,614			22,840			54,130			53,956			25,371			21,009
Commissions		144,243			51,841			352,782			215,144			171,086			99,279
Salaries and wages		324,869			200,425			937,400			578,038			350,404			257,860
Employee benefits		28,904			21,898			77,430			52,308			43,088			23,091
Taxes, licenses and fees		17,155			11,482			78,463			47,472			30,970			24,350
Office rent		22,479			20,205			69,274			60,481			22,759			20,486
Director fees		4,500			-			28,250			27,500			6,000			14,250
Third-party administration fees		36,522			52,846			131,636			143,220			69,704			44,309
Service and transfer agent fees		13,398			8,572			34,412			34,432			15,164			9,827
Travel, meals and entertainment		10,102			4,743			58,223			20,557			11,451			25,380
Professional fees		85,863			16,387			197,851			120,177			55,091			43,618
Furniture, equipment and software		12,014			7,412			34,362			25,107			6,284			8,891
Office and other expenses		56,728			29,935			124,080			89,740			60,472			47,393
Total benefits, claims and expenses		764,235			457,994			2,204,826			1,493,524			997,623			635,414
Net loss	$	(477,554	)	$	(254,013	)	$	(1,274,149	)	$	(877,342	)	$	(653,249	)	$	(376,918	)

Net loss per common share outstanding	$	(0.03	)	$	(0.02	)	$	(0.09	)	$	(0.06	)	$	(0.04	)	$	(0.03	)

	Three Months Ended September 30,						Nine Months Ended September 30,						Three Months Ended March 31,
	2019			2018			2019			2018			2020			2019

Net loss	$	(477,554	)	$	(254,013	)	$	(1,274,149	)	$	(877,342	)	$	(653,249	)	$	(376,918	)
Other comprehensive income (loss)
Total net unrealized gains (losses) arising during the period		133,298			(16,985	)		653,916			(191,972	)		(568,340	)		278,551
Adjustment to deferred acquisition costs		(490	)		95			(1,571	)		2,231			1,404			(683	)
Deferred taxes		(14,233	)		-			(49,081	)		-			87,104			(4,958	)
Total other comprehensive income (loss)		118,575			(16,890	)		603,264			(189,741	)		(479,832	)		272,910
Total comprehensive loss	$	(358,979	)	$	(270,903	)	$	(670,885	)	$	(1,067,083	)	$	(1,133,081	)	$	(104,008	)

~~Nine~~Three Months Ended ~~September~~ ~~30,~~March 31, 2020 and 2019 ~~and 2018~~

	Common Stock $.01 Par Value		Additional Paid-in Capital		Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Accumulated Deficit			Total Shareholders’ Equity			Common							Accumulated
Balance as of July 1, 2018	$	148,671	$	17,538,618	$	(20,000	)	$	(86,584	)	$	(4,841,528	)	$	12,739,177
																	Stock		Additional					Other
																	$.01 Par Value		Paid-in Capital		Treasury Stock			Comprehensive Income (Loss)			Accumulated Deficit			Total Shareholders’ Equity
Balance as of January 1, 2019																	$	148,671	$	17,538,618	$	(50,000	)	$	(162,781	)	$	(5,445,635	)	$	12,028,873
Purchase of treasury stock		-		-		-			-			-			-			-		-		(50,000	)		-			-			(50,000	)
Other comprehensive income																		-		-		-			272,910			-			272,910
Net loss																		-		-		-			-			(376,918	)		(376,918	)
Balance as of March 31, 2019																	$	148,671	$	17,538,618	$	(100,000	)	$	110,129		$	(5,822,553	)	$	11,874,865

Balance as of January 1, 2020																	$	148,671	$	17,538,618	$	(104,485	)	$	327,676		$	(7,237,665	)	$	10,672,815
Other comprehensive loss		-		-		-			(16,890	)		-			(16,890	)		-		-		-			(479,832	)		-			(479,832	)
Net loss		-		-		-			-			(254,013	)		(254,013	)		-		-		-			-			(653,249	)		(653,249	)
Balance as of September 30, 2018	$	148,671	$	17,538,618	$	(20,000	)	$	(103,474	)	$	(5,095,541	)	$	12,468,274

Balance as of July 1, 2019	$	148,671	$	17,538,618	$	(81,175	)	$	321,908		$	(6,242,230	)	$	11,685,792
Purchase of treasury stock		-		-		-			-			-			-
Treasury shares issued		-		-		-			-			-			-
Other comprehensive income		-		-		-			118,575			-			118,575
Net loss		-		-		-			-			(477,554	)		(477,554	)
Balance as of September 30, 2019	$	148,671	$	17,538,618	$	(81,175	)	$	440,483		$	(6,719,784	)	$	11,326,813
Balance as of March 31, 2020																	$	148,671	$	17,538,618	$	(104,485	)	$	(152,156	)	$	(7,890,914	)	$	9,539,734

Texas Republic Capital Corporation (the “Company”) is the parent holding company of Texas Republic Life Insurance Company (“TRLIC”) and Texas Republic Life Solutions, Inc. (“TRLS”). The Company was incorporated in Texas on May 15, 2012, for the primary purpose of forming and capitalizing a life insurance company subsidiary.

The Texas Department of Insurance approved TRLIC’s life insurance charter on August 1, 2016. The Company capitalized TRLIC with $3,000,000 and owns 100% of TRLIC. TRLIC began insurance operations on April 3, 2017 and is currently selling life and annuity products in the state of Texas. During 2018 the Company made capital contributions of $2,000,000 and $750,000 to TRLIC. During the second quarter of 2019 the Company made an additional capital contribution to TRLIC of mortgage loans valued at $857,133. During the third quarter of 2019 the Company made an additional capital contribution of $1,300,000 in cash to TRLIC bringing the total capitalization of TRLIC to $7,907,133. TRLS, an insurance agency, was incorporated February 1, 2017. The Company capitalized TRLS with $50,000 and owns 100% of TRLS. During 2018 the Company made an additional capital contribution of $100,000 bringing the total capitalization of TRLS to $150,000.

From incorporation through April 2, 2017, the Company was involved in the sale of common stock to provide working capital. During this time the Company completed an organizational offering, three private placement stock offerings and an intrastate public stock offering in the state of Texas. The Company raised $10,336,500 and incurred $1,215,569 of offering costs through the issuance of 12,865,000 shares from the organizational offering and three private placement offerings. The intrastate public stock offering was registered to raise $25,000,000 by offering 5,000,000 shares of its common stock and was ended on April 2, 2017. This offering raised $10,010,485 and incurred $1,444,127 of offering costs through the sale of 2,002,097 shares of the common stock.

The accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting primarily of normal recurring accruals) considered necessary for a fair presentation of the results for the interim periods have been included.

The results of operations for the three ~~and nine~~ months ended ~~September 30, 2019~~March 31, 2020 are not necessarily indicative of the results to be expected for the year ended December 31, ~~2019~~2020 or for any other interim period or for any other future year. Certain financial information which is normally included in notes to consolidated financial statements prepared in accordance with U.S. GAAP, but which is not required for interim reporting purposes, has been condensed or omitted. The accompanying consolidated financial statements and notes thereto should be read in conjunction with the financial statements and notes thereto included in the Company’s report on Form 10-K for the year ended December 31, ~~2018.~~2019.

As a result of Coronavirus Disease 2019, which was declared a pandemic on March 11, 2020, the United States Federal, State and Local Governments, and other countries around the world have taken measures that have suddenly limited economic output. Due to the decline in economic activity, the Company is faced with a sudden uncertainty as of the date of this report on its operations when considering its revenue sources and potential future liquidity needs. Management is actively monitoring the situation and the impact to the Company’s operations. As the pandemic continues, should liquidity conditions worsen in the short-term, management will work with its financial institutions to assist with liquidity needs.

The consolidated financial statements include the accounts and operations of the Company and its subsidiaries. All intercompany accounts and transactions are eliminated in consolidation.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although these estimates are based on management’s knowledge of current events and actions it may undertake in the future, they may ultimately differ from actual results.

Certain reclassifications have been made in the prior year financial statements to conform to current year classifications. These reclassifications had no effect on the previously reported net loss or shareholders equity.

Fixed maturity securities are comprised of bonds that are classified as available-for-sale and are carried at fair value with unrealized gains and losses, net of applicable income taxes, reported in accumulated other comprehensive ~~income.~~income (loss). The amortized cost of fixed maturity securities available-for-sale is generally adjusted for amortization of premium and accretion of discount.

Interest income, as well as the related amortization of premium and accretion of discount, is included in net investment income under the effective yield method. The amortized cost of fixed maturity securities available-for-sale is written down to fair value when a decline in value is considered to be other-than-temporary.

The Company evaluates the difference between the cost or amortized cost and estimated fair value of its investments to determine whether any decline in value is other-than-temporary in nature. This determination involves a degree of uncertainty. If a decline in the fair value of a security is determined to be temporary, the decline is recorded as an unrealized loss in shareholders’ equity. If a decline in a security’s fair value is considered to be other-than-temporary, the Company then determines the proper treatment for the other-than-temporary impairment. For fixed maturity securities, available-for-sale, the amount of any other-than-temporary impairment related to a credit loss is recognized in earnings and reflected as a reduction in the cost basis of the security; and the amount of any other-than-temporary impairment related to other factors is recognized in other comprehensive income (loss) with no change to the cost basis of the security.

The assessment of whether a decline in fair value is considered temporary or other-than-temporary includes management’s judgment as to the financial position and future prospects of the entity issuing the security. It is not possible to accurately predict when it may be determined that a specific security will become impaired. Future adverse changes in market conditions, poor operating results of underlying investments and defaults on mortgage loan payments could result in losses or an inability to recover the current carrying value of the investments, thereby possibly requiring an impairment charge in the future.

Likewise, if a change occurs in the Company’s intent to sell temporarily impaired securities prior to maturity or recovery in value, or if it becomes more likely than not that the Company will be required to sell such securities prior to recovery in value or maturity, a future impairment charge could result. If an other-than-temporary impairment related to a credit loss occurs with respect to a bond, the Company amortizes the reduced book value back to the security’s expected recovery value over the remaining term of the bond. The Company ~~will continue~~continues to review the security for further impairment that would prompt another write-down in the value.

Purchases and sales of securities are recorded on a trade-date basis. Interest earned on investments is recorded on the accrual basis and is included in net investment income.

The Company’s mortgage loan portfolio is comprised of residential properties with loan to appraised value ratios ~~at or~~ below ~~91%~~90%. Mortgage loans are carried at current book value.

The Company’s other long-term investments are comprised of lottery prize cash flows holdings held at amortized cost. They are categorized as other long-term investments in the statement of financial position and are assignments of the future rights from lottery winners purchased at a discounted price. Payments on these investments are made by state run lotteries.

Costs that relate to and vary with the successful production of new business are deferred over the life of the policy. Deferred acquisition costs (“DAC”) consist of commissions and policy issuance, underwriting and agency expenses. DAC expenses are amortized primarily over the premium-paying period of life policies and as profits emerge on annuity products. Amortization uses the same assumptions as were used in computing liabilities for future policy benefits. There was ~~$305,757~~$135,177 of DAC deferred for the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 and ~~$54,130~~$25,371 of DAC amortized for the ~~nine months ended September 30, 2019. For the~~ three months ended ~~September 30, 2019 there was $115,949 of DAC deferred and $15,614 of DAC amortized.~~March 31, 2020. There was ~~$188,220~~$91,949 of DAC deferred for the ~~nine~~three months ended ~~September 30, 2018~~March 31, 2019 and ~~$53,956~~$21,009 of DAC amortized for the ~~nine months ended September 30, 2018. For the~~ three months ended ~~September 30, 2018 there was $42,102 of DAC deferred and $22,840 of DAC amortized.~~March 31, 2019.

Sales inducement costs (“SIC”) are related to policy bonuses issued on some of the Company’s annuity products. SIC is deferred at the issuance of the policy and amortized over the ~~shorter of the~~ bonus period ~~or the life of the policy based~~ on ~~the expected future profits of the business.~~a straight-line basis. The amount deferred is based on the difference between the fund value with the bonus and the fund value without the bonus. ~~There~~The deferred SIC asset was ~~$508,161~~$953,361 and $770,177 at March 31, 2020 and December 31, 2019, respectively. For the three months ended March 31, 2020 there was $230,124 of SIC deferred ~~for the nine months ended September 30, 2019~~ and ~~$22,810~~$46,940 of SIC amortized. There was $126,159 of SIC deferred and $4,849 of SIC amortized for the ~~nine months ended September 30, 2019. For the~~ three months ended September 30, 2019 there was $230,004 of SIC deferred and $8,341 of SIC amortized. There was $100,103 of SIC deferred for the nine months ended September 30, 2018 and $3,703 of SIC amortized for the nine months ended September 30, 2018. For the three months ended September 30, 2018 there was $27,124 of SIC deferred and $1,943 of SIC amortized.March 31, 2019.

Advances and notes receivable are recorded at unpaid principal balances. Management evaluates the collectability of advances and notes receivable on the specific identification basis. Uncollectible amounts are reported in the results of operations in the year the determination is made.

In February 2016, the FASB issued ASU 2016-02, Lease Accounting (Topic 842) (“ASU 2016-02”). Under ASU 2016-02, a lessee is required to recognize assets and liabilities for leases with lease terms of more than twelve months. The Company’s home office lease has a term greater than one year, and the Company recognizes on the balance sheet ~~as of January 1, 2019~~ a right of use (“ROU”) operating lease asset and a lease liability, initially measured at the present value of the lease payments. Lease costs are recognized in the income statement over the lease term on a straight-line basis. ROU assets represent ~~the Company’s~~our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. The Company ~~amortized $54,362 and $18,335 of the~~has a lease asset and liability ~~for the nine and three months ending September 30, 2019, respectively.~~of $227,607 as of March 31, 2020 compared to $248,298 as of December 31, 2019.

Furniture and equipment are carried at cost less accumulated depreciation or amortization. Office furniture, equipment and EDP equipment is recorded at cost or fair value at acquisition less accumulated depreciation or amortization using the straight-line method over the estimated useful life of the respective assets of three to seven years.

The Company’s liability for policyholders’ account balances represents the contract value that has accrued to the benefit of the policyholder as of the financial statement date. This liability is generally equal to the accumulated account deposits plus applicable bonus and interest credited less policyholders’ withdrawals and other charges assessed against the account balance. Interest crediting rates for individual annuities range from ~~3.24%~~2.54% to 5.00%.

Future policy benefit reserves have been computed by the net level premium method with assumptions as to investment yields, mortality and withdrawals based upon the Company’s experience. The preparation of financial statements requires management to make estimates and assumptions that affect the reported amount of policy liabilities and the increase in future policy benefit reserves. Management’s judgments and estimates for future policy benefit reserves provide for possible unfavorable deviation.

Common stock is fully paid, non-assessable and has a par value of $.01 per share.

Treasury stock, representing shares of the Company’s common stock that have been reacquired after having been issued and fully paid, are recorded at cost.

The Company uses the asset and liability method of accounting for income taxes. Deferred income taxes are provided for cumulative temporary differences between balances of assets and liabilities determined under GAAP and balances determined using tax bases. The Company has a valuation allowance to fully offset the net deferred tax asset.

Net loss per common share is calculated using the weighted average number of common shares outstanding during the year. The weighted average common shares outstanding were ~~14,814,895~~14,764,587 and ~~14,863,319 for the nine months ended September 30, 2019 and 2018, respectively. The weighted average common shares outstanding were 14,801,587 and 14,862,097~~14,841,764 for the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018,~~ respectively.

~~During 2018 the~~The Company entered into an agreement with First Trinity Financial Corporation (“FTFC”) where FTFC will use its resources to source mortgages on real estate and lottery bonds. FTFC will present to the Company investments based on criteria the Company has established. The Company has the option to purchase the presented investment assets directly from the seller or to decline the purchase based on the Company’s analysis of the investment. All mortgages and lottery bonds that were purchased by the Company in ~~2019~~2020 and ~~2018~~2019 were obtained through this agreement. The Chairman of the Company is also the Chairman, President and Chief Executive Officer of FTFC.

Management has evaluated subsequent events for recognition and disclosure in the financial statements through the date the financial statements were available to be issued.

~~In August 2016, the FASB issued ASU 2016-15,~~ ~~“Statement of Cash Flows: Classification of Certain Cash Receipts and Cash Payments”~~ (“ASU 2016-15”). ASU 2016-15 adds or clarifies guidance on the classification of certain cash receipts and payments in the statement of cash flows, including, but not limited to: (1) debt prepayment or debt extinguishment costs; (2) settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; (3) contingent consideration payments made after a business combination; (4) proceeds from the settlement of insurance claims; (5) proceeds from the settlement of corporate-owned life insurance policies, including bank-owned life insurance policies; (6) distributions received from equity method investees; (7) beneficial interests in securitization transactions and (8) separately identifiable cash flows and application of the predominance principle. ASU 2016-15 is effective, with retrospective adoption, for annual periods beginning after December 15, 2017, and interim periods within those fiscal years. Adoption of this guidance did not have any material impact on the Company’s financial condition or results of operations.

~~In March 2017, the FASB issued~~ ~~ASU 2017-08~~~~, “~~~~Receivables-Nonrefundable Fees and Other Costs: Premium Amortization on Purchased Callable Debt Securities~~” (“ASU 2017-08”). ASU 2017-08 revises the amortization period for certain callable debt securities held at a premium, requiring the premium to be amortized to the earliest call date. Under current GAAP, entities generally amortize the premium as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 with early adoption permitted. The Company is in the process of evaluating the securities the Company owns which were purchased at a premium to determine the impact this guidance will have on the consolidated financial statements.

~~In January 2016, the FASB issued ASU 2016-01,~~ ~~Financial Instruments – “Overall: Recognition and Measurement of Financial Assets and Financial Liabilities”~~ (“ASU 2016-01”). ASU 2016-01 provides guidance to improve certain aspects of recognition, measurement, presentation, and disclosure of financial instruments. Specifically, the guidance: (1) Require equity investments (except those accounted for under the equity method of accounting or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income. However, an entity may choose to measure equity investments that do not have readily determinable fair values at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. (2) Simplify the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value. (3) Eliminate the requirement to disclose the fair value of financial instruments measured at amortized cost for entities that are not public business entities. (4) Eliminate the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost on the balance sheet. (5) Require public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes. (6) Require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. (7) Require separate presentation of financial assets and financial liabilities by measurement category and form of financial asset (that is, securities or loans and receivables) on the balance sheet or the accompanying notes to the financial statements. (8) Clarify that an entity should evaluate the need for a valuation allowance on a deferred tax asset related to available-for-sale securities in combination with the entity’s other deferred tax assets. ASU 2016-01 is effective for annual periods beginning after December 15, 2017, including interim periods within those annual periods. The adoption of this guidance did not have a significant impact on the Company’s financial statements.

In February 2016, the FASB issued ASU 2016-02, “Leases” (“ASU 2016-02”). ASU 2016-02 requires all lessees to recognize a lease liability and a right-of-use asset (“ROU”), measured at the present value of the future minimum lease payments, at the lease commencement date. ASU 2016-02 is effective for fiscal years beginning after December 15, 2018, including interim reporting periods within that fiscal year, with early adoption permitted. ASU 2016-02 requires the application of a modified retrospective approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements.

In July 2018, the FASB issued updated guidance (Accounting Standards Update 2018-11) that provides entities with an additional (and optional) transition method to adopt the new standard on leases. Under this new transition method, an entity initially applies the new standard on leases at the adoption date and recognizes a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption. Consequently, an entity’s reporting for the comparative periods presented in the financial statements in which it adopts the new standard on leases will continue to be in accordance with current GAAP (Topic 840, Leases). An entity that elects this additional (and optional) transition method must provide the required Topic 840 disclosures for all periods that continue to be in accordance with Topic 840.

The Company adopted ASU 2016-02, as of January 1, 2019. The Company elected to utilize the cumulative-effect adjustment to the opening balance of retained earnings for the year of adoption. Accordingly, the Company’s reporting for the comparative periods prior to adoption continue to be presented in the financial statements in accordance with previous lease accounting guidance. The Company also elected to apply all practical expedients applicable to the Company in the updated guidance for transition for the lease in effect at adoption, including using hindsight to determine the lease term of the existing leases, the option to not reassess whether an existing contract is a lease or contains a lease and whether the lease is an operating or finance lease. The Company increased assets and liabilities by $331,065 at the adoption date.

In September 2016, the FASB issued ASU 2016-13, “Financial Instruments - Credit Losses: Measurement of Credit Losses on Financial Instruments” (“ASU 2016-13”). ASU 2016-13 will change the way entities recognize impairment of financial assets by requiring immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, including, among others, held-to-maturity debt securities, mortgage loans, lottery prize receivables, trade receivables, and reinsurance recoverables. ASU 2016-13 requires a valuation allowance to be calculated on these financial assets and that they be presented on the financial statements net of the valuation allowance. This methodology is referred to as the current expected credit loss model. ASU 2016-13 had an original effective date for fiscal years beginning after December 15, 2019, including interim periods within those annual periods. The FASB recently delayed the effective date of ASU 2016-13 to fiscal years beginning after December 15, 2022 for smaller reporting companies, with early adoption permitted. The Company is currently evaluating the impact of this guidance on the Company’s financial condition and results of operations. However, currently the Company does not expect a material impact on the Company’s financial condition or results of operations from the adoption of this guidance.

In January 2017, the FASB issued ASU 2017-04, “Intangibles — Goodwill and Other” (“ASU 2017-04”). ASU 2017-04 ~~will amend~~amends and ~~simplify~~simplifies current goodwill impairment testing to eliminate Step 2 from the current provisions. Under the new guidance, an entity should perform the goodwill impairment test by comparing the fair value of a reporting unit with its carrying value and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. An entity still has the option to perform the quantitative assessment for a reporting unit to determine if a quantitative impairment test is necessary. ASU 2017-04 ~~will be~~is effective for annual or any interim goodwill impairment tests in fiscal years beginning after December 15, 2019. ~~As the~~The Company ~~currently has no Goodwill on its balance sheet,~~adopted ASU 2017-04 isas of January 1, 2020. The adoption of this guidance did not ~~expected to~~ have ~~an impact~~a material effect on the Company’s ~~financial condition or~~ results of ~~operations.~~ operations, financial position or liquidity.

In March 2017, the FASB issued ASU 2017-08, “Receivables-Nonrefundable Fees and Other Costs: Premium Amortization on Purchased Callable Debt Securities” (“ASU 2017-08”). ASU 2017-08 revises the amortization period for certain callable debt securities held at a premium, requiring the premium to be amortized to the earliest call date. Under current GAAP, entities generally amortize the premium as an adjustment of yield over the contractual life of the instrument. ASU 2017-08 is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019 with early adoption permitted. The Company adopted ASU 2017-08 as of January 1, 2020. The adoption of this guidance did not have a material effect on the Company’s results of operations, financial position or liquidity.

In February 2018, the FASB issued ASU 2018-02, “Income Statement — Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income” (“ASU 2018-02”). ASU 2018-02 was issued to address the income tax accounting treatment of the stranded tax effects within other comprehensive income from the prohibition of backward tracing due to an income tax rate change that was initially recorded in other comprehensive income. This issue came about from the enactment of the Tax Cuts and Jobs Act on December 22, 2017 that changed the Company’s income tax rate from 35% to 21%. The ASU changed current accounting whereby an entity may elect to reclassify the stranded tax effect from accumulated other comprehensive income to retained earnings. The ASU is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The Company adopted ASU 2018-02 as of January 1, 2019. The adoption of this guidance did not have a material effect on the Company’s results of operations, financial position or liquidity.

In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement”(“ASU No. 2018-13”). This ASU eliminates, adds and modifies certain disclosure requirements for fair value measurements. Among the changes, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, but will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU No. 2018-13 is effective for interim and annual reporting periods beginning after December 15, 2019; early adoption is permitted. Entities may early adopt any eliminated or modified disclosure requirements and delay adoption of the additional disclosure requirements until their effective date. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption of this guidance did not have a material effect on the Company’s results of operations, financial position or liquidity.

In August 2018, the FASB issued ASU 2018-12 Financial Services-Insurance (Topic 944) - Targeted Improvements to the Accounting for Long-Duration Contracts. This update is aimed at improving the Codification related to long-duration contracts which will improve the timeliness of recognizing changes in the liability for future policy benefits, simplify accounting for certain market-based options, simplify the amortization of deferred acquisition costs, and improve the effectiveness of required disclosures. The amendments require an insurance entity to review and update assumptions used to measure cash flows at least annually and to update discount rate assumption at each reporting date. The amendment requires an insurance entity to measure all market risk benefits associated with deposit contracts at fair value, with change in fair value attributable to change in instrument-specific credit risk recognized in other comprehensive income. Additionally, the amendment will simplify amortization of deferred acquisition costs and other balances amortized in proportion to premiums, gross profits, or gross margins and require those balances be amortized on constant level basis over the expected term of the related contract. Deferred acquisition costs are required to be written off for unexpected contract terminations but are not subject to impairment test. The amendment further requires an insurance entity to add disclosures of disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities, and deferred acquisition costs. The insurance entity must also disclose information about significant inputs, judgments, assumptions, and methods used in measurement, including changes in those inputs, judgments, and assumptions, and the effect of those changes on measurement. These updates are originally required to be applied retrospectively to the earliest period presented in the financial statements for periods beginning after December 15, 2020. The FASB recently delayed the effective date of ASU 2018-12 to December 15, 2023 for smaller reporting companies, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

~~In August 2018, the FASB issued~~ ~~ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement~~”(“ASU No. 2018-13”). This ASU eliminates, adds and modifies certain disclosure requirements for fair value measurements. Among the changes, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, but will be required to disclose the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements. ASU No. 2018-13 is effective for interim and annual reporting periods beginning after December 15, 2019; early adoption is permitted. Entities may early adopt any eliminated or modified disclosure requirements and delay adoption of the additional disclosure requirements until their effective date. The Company is currently evaluating the impact of the new guidance on its consolidated financial statements.

~~In February 2018, the FASB issued~~ ~~ASU 2018-02, “Income Statement — Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income”~~ (“ASU 2018-02”). ASU 2018-02 was issued to address the income tax accounting treatment of the stranded tax effects within other comprehensive income from the prohibition of backward tracing due to an income tax rate change that was initially recorded in other comprehensive income. This issue came about from the enactment of the Tax Cuts and Jobs Act on December 22, 2017 that changed the Company’s income tax rate from 35% to 21%. The ASU changed current accounting whereby an entity may elect to reclassify the stranded tax effect from accumulated other comprehensive income to retained earnings. The ASU is effective for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. The adoption of ASU 2018-02 did not have a significant impact on the Company’s financial statements.

Investments in fixed maturity securities available-for-sale as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019 are summarized as follows:

			Gross		Gross						Gross		Gross
	Amortized		Unrealized		Unrealized		Fair		Amortized		Unrealized		Unrealized		Fair
September 30, 2019 (Unaudited)	Cost		Gains		Losses		Value
March 31, 2020 (Unaudited)									Cost		Gains		Losses		Value
Fixed maturity securities
Corporate bonds	$	8,106,196	$	534,808	$	44,303	$	8,596,701	$	8,780,402	$	350,962	$	503,513	$	8,627,851
Total fixed maturity securities	$	8,106,196	$	534,808	$	44,303	$	8,596,701	$	8,780,402	$	350,962	$	503,513	$	8,627,851

			Gross		Gross						Gross		Gross
	Amortized		Unrealized		Unrealized		Fair		Amortized		Unrealized		Unrealized		Fair
December 31, 2018	Cost		Gains		Losses		Value
December 31, 2019									Cost		Gains		Losses		Value
Fixed maturity securities
Corporate bonds	$	6,828,467	$	25,916	$	189,327	$	6,665,056	$	7,673,671	$	456,779	$	40,990	$	8,089,460
Total fixed maturity securities	$	6,828,467	$	25,916	$	189,327	$	6,665,056	$	7,673,671	$	456,779	$	40,990	$	8,089,460

For securities in an unrealized loss position as of the financial statement dates, the estimated fair value, pre-tax gross unrealized loss and number of securities by length of time that those securities have been continuously in an unrealized loss position as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019 are summarized as follows:

			Unrealized		Number of				Unrealized		Number of
September 30, 2019 (Unaudited)	Fair Value		Loss		Securities
March 31, 2020 (Unaudited)							Fair Value		Loss		Securities
Fixed maturity securities
Less than 12 months
Corporate bonds	$	211,822	$	2,876		2	$	2,716,460	$	424,330		26

Greater than 12 months
Corporate bonds		358,477		41,427		3		21,750		79,183		1
Total fixed maturity securities	$	570,299		44,303		5	$	2,738,210	$	503,513		27

			Unrealized		Number of				Unrealized		Number of
December 31, 2018	Fair Value		Loss		Securities
December 31, 2019							Fair Value		Loss		Securities
Fixed maturity securities
Less than 12 months
Corporate bonds	$	4,321,663	$	170,332		36	$	602,772	$	8,050		5

Greater than 12 months
Corporate bonds		82,500		18,995		1		366,310		32,940		3
Total fixed maturity securities	$	4,404,163	$	189,327		37	$	969,082	$	40,990		8

~~The~~As of March 31, 2020, the twenty-six fixed maturity securities in a less than 12-month loss position had a fair value to amortized cost ratio of ~~at least 75.0% as of September 30, 2019 and at least 80% as of December 31, 2018. One~~86%. The fixed maturity security ~~with~~in a ~~par value of $100,000 and currently in an unrealized~~ loss position ~~is below investment grade as rated by Standard and Poor’s~~greater than 12-months had a fair value to amortized cost ratio of 21.5% as of ~~September 30, 2019. One additional fixed maturity security with a par value of $150,000 in a realized gain position is also below investment grade as of September 30, 2019.~~March 31, 2020. Two securities with a par value of $250,000 were below investment grade as rated by Standard and Poor’s as of March 31, 2020 and December 31, ~~2018.~~2019. As of December 31, 2019, seven of the eight fixed maturity securities in a loss position had a fair value to amortized cost ratio greater than 97%. The one fixed security that was below 97% at December 31, 2019 was at 72%. The five securities in a less than 12-month loss position had an average fair value to amortized cost ratio of over 98%. The two of the three securities in a loss position greater than 12-months had a fair value to amortized cost ratio of over 98% of December 31, 2019. The remaining security mentioned just above had a fair value to amortized cost ratio of over 72%.

The Company’s decision to record an impairment loss is primarily based on whether the security’s fair value is likely to remain significantly below its book value based on all of the factors considered. Factors that are considered include the length of time the security’s fair value has been below its carrying amount, the severity of the decline in value, the credit worthiness of the issuer and the coupon and/or dividend payment history of the issuer. The Company also assesses whether it intends to sell or whether it is more likely than not that it may be required to sell the security prior to its recovery in value.

For any fixed maturity securities that are other-than-temporarily impaired, the Company determines the portion of the other-than-temporary impairment that is credit-related and the portion that is related to other factors. The credit-related portion is the difference between the expected future cash flows and the amortized cost basis of the fixed maturity security, ~~and~~ that difference is charged to earnings. The non-credit-related portion representing the remaining difference to fair value is recognized in other comprehensive income (loss).

Only in the case of a credit-related impairment where management has the intent to sell the security, or it is more likely than not that it will be required to sell the security before recovery of its cost basis, is a fixed maturity security adjusted to fair value and the resulting losses recognized in realized gains (losses) in the consolidated statements of operations. Any other-than-temporary impairments on equity securities are recorded in the consolidated statements of operations in the periods incurred as the difference between fair value and cost.

Based on management’s review, the Company experienced no other-than-temporary impairments during the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 and the year ended December 31, ~~2018.~~2019.

Management believes that the Company will fully recover its cost basis in the securities held as of ~~September 30, 2019,~~March 31, 2020, and management does not have the intent to sell nor is it more likely than not that the Company will be required to sell such securities until they recover or mature. The temporary impairments shown herein are primarily the result of the current interest rate environment rather than credit factors that would imply other-than-temporary impairment. These unrealized losses were primarily due to the Coronavirus pandemic impact on the bond market as of March 31, 2020.

Net unrealized gains (losses) included in accumulated other comprehensive income for investments classified as available-for-sale are summarized as follows:

	(Unaudited)						(Unaudited)
	September 30, 2019			December 31, 2018			March 31, 2020			December 31, 2019
Unrealized appreciation (depreciation) on available-for-sale securities	$	490,505		$	(163,411	)	$	(152,551	)	$	415,789
Adjustment to deferred acquisition costs		(941	)		630			395			(1,009	)
Deferred taxes		(49,081	)		-			-			(87,104	)
Net unrealized appreciation (depreciation) on available-for-sale securities	$	440,483		$	(162,781	)	$	(152,156	)	$	327,676

The amortized cost and fair value of fixed maturity available-for-sale securities as of ~~September 30, 2019,~~March 31, 2020, by contractual maturity, are summarized as follows:

	(Unaudited)				(Unaudited)
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Due after one year through five years	$	2,765,503	$	2,882,013	$	3,217,659	$	3,124,870
Due after five years through ten years		3,337,669		3,577,374		3,287,659		3,303,769
Due after ten years		2,003,024		2,137,314		2,275,084		2,199,212
Total fixed maturity securities	$	8,106,196	$	8,596,701	$	8,780,402	$	8,627,851

The amortized cost and fair value of other long-term investments as of ~~September 30, 2019,~~March 31, 2020, by contractual maturity, are summarized as follows:

	(Unaudited)				(Unaudited)
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Due in one year or less	$	410,050	$	425,070	$	669,776	$	690,072
Due after one year through five years		1,265,617		1,456,889		1,786,873		2,040,303
Due after five years through ten years		369,256		496,983		359,954		480,552
Due after ten years		31,339		50,931		22,715		36,784
Total other long-term investments	$	2,076,262	$	2,429,873	$	2,839,318	$	3,247,711

Expected maturities may differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without call or prepayment penalties.

The Company utilizes the ratio of the carrying value of individual mortgage loans compared to the individual appraisal value to evaluate the credit quality of its mortgage loans on real estate (commonly referred to as the loan-to-value ratio). ~~Currently, all of the Company’s mortgage loans are loans on residential properties.~~ The Company’s mortgage loans on real estate by credit quality using this ratio as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~ 2019are summarized as follows:

Loan-To-Value-Ratio	(Unaudited) September 30, 2019		December 31, 2018
90% or higher	$	95,571	$	-
					March 31, 2020		December 31, 2019
Over 90%					$	-	$	96,480
80% to 90%		83,376		-		95,978		145,388
70% to 80%		182,323		75,947		329,254		184,168
60% to 70%		1,235,087		573,506		1,163,598		1,548,486
50% to 60%		766,144		677,169		723,699		824,354
40% to 50%		111,172		118,408		152,177		109,665
Total	$	2,473,673	$	1,445,030	$	2,464,706	$	2,908,541

There were 9 loans with a remaining principal balance of $793,819 that were 90 days or more past due and still accruing interest as of March 31, 2020. There were 8 loans with a remaining principal balance of $698,090 that were 90 days or more past due and still accruing interest as of December 31, 2019.

Major categories of net investment income for the three ~~and nine~~ months ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~ are summarized as follows:

	(Unaudited)						(Unaudited)
	Three Months Ended September 30,						Nine Months Ended September 30,						For the Three Months Ended March 31,
	2019			2018			2019			2018			2020			2019

Fixed maturity securities	$	70,293		$	64,279		$	219,966		$	144,626		$	82,929		$	74,547
Other long-term assets		42,707			5,682			83,571			16,289			54,962			12,075
Mortgage loans		36,684			13,276			90,251			19,505			46,856			25,427
Short-term and other investments		55,683			33,920			133,788			82,733			38,433			32,577
Gross investment income		205,367			117,157			527,576			263,153			223,180			144,626
Investment expenses		(2,460	)		(3,191	)		(14,451	)		(13,305	)		(6,204	)		(8,055	)
Net investment income	$	202,907		$	113,966		$	513,125		$	249,848		$	216,976		$	136,571

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) on the measurement date. The Company also considers the impact on fair value of a significant decrease in volume and level of activity for an asset or liability when compared with normal activity.

The Company holds fixed maturity securities that are measured and reported at fair market value on the consolidated statement of financial position. The Company determines the fair market values of its financial instruments based on the fair value hierarchy that requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value, as follows:

Level 1 - Quoted prices in active markets for identical assets or liabilities. The Company has no Level 1 assets that would include securities traded in an active exchange market.

Level 2 - Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. The Company’s Level 2 assets and liabilities include fixed maturity securities with quoted prices that are traded less frequently than exchange-traded instruments or assets and liabilities whose value is determined using a pricing model with inputs that are observable in the market or can be derived principally from or corroborated by observable market data. This category generally includes U.S. Government and agency mortgage-backed debt securities and corporate debt securities.

Level 3 - Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation. This category generally includes investments where independent pricing information was not able to be obtained for a significant portion of the underlying assets.

The Company has categorized its financial instruments, based on the priority of the inputs to the valuation technique, into the three-level fair value hierarchy. If the inputs used to measure the financial instruments fall within different levels of the hierarchy, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the valuation inputs, or their ability to be observed, may result in a reclassification for certain financial assets or liabilities. Reclassifications impacting the levels of the fair value hierarchy are reported as transfers in and out of the specific level category as of the beginning of the period in which the reclassifications occur.

The Company’s fair value hierarchy for those financial instruments measured at fair value on a recurring basis as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019 are summarized as follows:

September 30, 2019 (Unaudited)	Level 1		Level 2		Level 3		Total
March 31, 2020 (Unaudited)									Level 1		Level 2		Level 3		Total
Fixed maturity securities, available-for-sale
Corporate bonds	$	-	$	8,596,701	$	-	$	8,596,701	$	-	$	8,627,851	$	-	$	8,627,851
Total fixed maturity securities	$	-	$	8,596,701	$	-	$	8,596,701	$	-	$	8,627,851	$	-	$	8,627,851

December 31, 2018	Level 1		Level 2		Level 3		Total
December 31, 2019									Level 1		Level 2		Level 3		Total
Fixed maturity securities, available-for-sale
Corporate bonds	$	-	$	6,665,056	$	-	$	6,665,056	$	-	$	8,089,460	$	-	$	8,089,460
Total fixed maturity securities	$	-	$	6,665,056	$	-	$	6,665,056	$	-	$	8,089,460	$	-	$	8,089,460

Fair values for Level 2 assets for the Company’s fixed maturity securities available-for-sale are primarily based on prices supplied by a third-party investment service. The third-party investment service provides quoted prices in the market which use observable inputs in developing such rates.

The Company analyzes market valuations received to verify reasonableness and to understand the key assumptions used and the sources. Since the fixed maturity securities owned by the Company do not trade on a daily basis, the third-party investment service prepares estimates of fair value measurements using relevant market data, benchmark curves, sector groupings and matrix pricing. As the fair value estimates of the Company’s fixed maturity securities are based on observable market information rather than market quotes, the estimates of fair value on these fixed maturity securities are included in Level 2 of the hierarchy. The Company’s Level 2 investments ~~include~~includes U.S. Government and agency mortgage-backed debt securities and corporate ~~bonds.~~debt securities.

The Company’s fixed maturity securities available-for-sale portfolio is highly liquid and allows for a high percentage of the portfolio to be priced through pricing services.

The carrying amount and fair value of the Company’s financial assets and financial liabilities disclosed, but not carried, at fair value as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019 and the level within the fair value hierarchy at which such assets and liabilities are measured on a recurring basis are summarized as follows:

											March 31, 2020 (Unaudited)
	September 30, 2019 (Unaudited)										Carrying		Fair
	Carrying		Fair								Amount		Value		Level 1		Level 2		Level 3
Financial assets	Amount		Value		Level 1		Level 2		Level 3
Cash and cash equivalents	$	11,327,582	$	11,327,582	$	11,327,582	$	-	$	-	$	17,845,572	$	17,845,572	$	17,845,572	$	-	$	-
Mortgages on real estate		2,473,673		2,423,213		-		-		2,423,213		2,464,706		2,570,283		-		-		2,570,283
Other long-term investments		2,076,262		2,429,873		-		-		2,429,873		2,839,318		3,247,711		-		-		3,247,711
Accrued investment income		104,378		104,378		-		-		104,378		139,581		139,581		-		-		139,581
Advances and notes receivable		171,270		171,270		-		-		171,270		176,821		176,821		-		-		176,821
Total financial assets	$	16,153,165	$	16,456,316	$	11,327,582		-	$	5,128,734	$	23,465,998	$	23,979,968	$	17,845,572	$	-	$	6,134,396

Financial liabilities
Policyholders’ account balances	$	13,802,901		12,040,056	$	-	$	-		12,040,056	$	23,497,676	$	21,787,008	$	-	$	-	$	21,787,008
Policy claims		46,083		46,083		-		-		46,083		62,114		62,114		-		-		62,114
Total financial liabilities	$	13,848,984	$	12,086,139	$	-	$	-	$	12,086,139	$	23,559,790	$	21,849,122	$	-	$	-	$	21,849,122

The estimated fair value amounts have been determined using available market information and appropriate valuation methodologies. However, considerable judgment was required to interpret market data to develop these estimates. Accordingly, the estimates are not necessarily indicative of the amounts which could be realized in a current market exchange. The use of different market assumptions or estimation methodologies may have a material effect on the fair value amounts.

The following methods and assumptions were used in estimating the fair value disclosures for financial instruments in the accompanying financial statements and notes thereto:

The fair value of fixed maturity securities is based on the principles previously discussed as Level 1, Level 2 and Level 3.

Cash and Cash Equivalents, Accrued Investment Income and Advances and Notes Receivable

The carrying value of these financial instruments approximates their fair values due to the expected short-term nature until the cash settlement of these items. Cash and cash equivalents are included in Level 1 of the fair value hierarchy due to their highly liquid nature. Accrued investment income and advances and notes receivable are included in Level 3 of the fair value hierarchy due to little or no availability of market activity for these types of assets.

The Company’s mortgage loan portfolio is comprised of residential properties with loan to appraised value ratios ~~at or~~ below ~~91%~~90%. The fair values for mortgage loans are estimated using discounted cash flow analyses. For residential mortgage loans, the discount rate used was indexed to the LIBOR yield curve adjusted for an appropriate credit spread.

Other long-term investments are comprised of lottery prize receivables and fair value is derived by using a discounted cash flow approach. Projected cash flows are discounted using the average FTSE Pension Liability Index in effect at the end of each period.

The fair value for liabilities under investment-type insurance contracts (accumulation annuities) is calculated using a discounted cash flow approach. Cash flows are projected using actuarial assumptions and discounted to the valuation date using risk-free rates adjusted for credit risk and the nonperformance risk of the liabilities.

The fair values for insurance contracts other than investment-type contracts are not required to be disclosed.

The carrying amounts reported for these liabilities approximate their fair value.

The Company files a consolidated return with its subsidiary TRLS. The Company’s other subsidiary TRLIC files a separate federal return for life insurance companies. TRLIC is taxed as a life insurance company under the provisions of the Internal Revenue Code. Life insurance companies must file separate tax returns until they have been a member of the consolidated filing group for five years. Certain items included in income reported for financial statement purposes are not included in taxable income for the current period, resulting in deferred income taxes.

The Company has net operating loss carryforwards of approximately $3.6 million expiring in 2032 through 2037. The company also has ~~$525,919~~$598,288 of loss carryforwards from 2018 ~~and 2019~~through 2020 that will not expire. A valuation allowance of ~~$863,670~~$878,868 has been established for net operating losses arising from 2012 through ~~2019~~2020 since the Company has not demonstrated the ability to generate taxable income. As of ~~September 30, 2019,~~March 31, 2020, TRLIC has ~~$1,896,702~~$2,571,936 in operating loss carryforwards that have originated since 2016. In accordance with the Tax Cuts and Jobs Act of 2017, $588,407 of the operating loss carryforwards were generated prior to January 1, 2018 and will expire in 2031 and 2032. Additionally, TRLIC has loss carryforwards of ~~$1,308,295~~$1,983,529 from 2018 ~~and 2019~~through 2020 which will not expire. TRLIC’s operating loss carryforwards ~~has~~have a valuation allowance of ~~$398,307~~$540,107 against it at ~~September 30, 2019,~~March 31, 2020, as TRLIC has not yet demonstrated the ability to generate taxable income. The utilization of those losses is restricted by the tax laws and some or all the losses may not be available for use.

The Company and its subsidiaries have no known uncertain tax benefits within its provision for income taxes. In addition, the Company does not believe it would be subject to any penalties or interest relative to any open tax years and, therefore, have not accrued any such amounts. The Company files U.S. federal income tax returns and income tax returns in various state jurisdictions. The 2016 through 2018 U.S. federal tax years are subject to income tax examination by tax authorities. The Company classifies any interest and penalties (if applicable) as income tax expense in the financial statements.

The Company maintains cash and cash equivalents at multiple institutions. The Federal Deposit Insurance Corporation insures non-interest-bearing accounts up to $250,000. ~~The uninsured~~Uninsured balances aggregate ~~to $38,618~~$911,571 as of ~~September 30, 2019.~~March 31, 2020. The Company monitors the solvency of all financial institutions in which it has funds to minimize the exposure for loss. The Company has not experienced any losses in these accounts and believes it is not exposed to any significant credit risk on cash and cash equivalents.

The Company’s Agent Stock Incentive Plan (“ASIP”) was approved in August 2018 by the Texas State Securities Board. The plan awards shares of Texas Republic Capital Corporation common stock to agents based on certain production levels achieved in sales of life and annuity products. Calculation of awards at December 31, 2019 were based on production for the period of January through December 2019. The ASIP will issue 4,120 shares awarded on 2019 production. The ASIP issued ~~11,490~~1,490 shares ~~during~~in 2019 based on 2018 production. Also, in 2019 the ~~first nine months~~Company issued 10,000 shares as part of ~~2019.~~an employment agreement.

The Company rents office space for certain administrative operations under an agreement that expires in 2022. The lease includes an option to extend or renew the lease term. The operating lease liability includes lease payments related to options to extend or renew the lease term only if the Company is reasonably certain of exercising those options. The exercise of the renewal option is at the Company's discretion; at this time there is uncertainty as to the Company exercising its renewal option so the option is not included in the determination of the present value calculation. In determining the present value of lease payments, the Company uses its incremental borrowing rate obtained from its main commercial bank.

Future payments under operating lease arrangements accounted for under ASC Topic 842 as of ~~September 30, 2019~~March 31, 2020 are as follows:

2019 (remaining)	$	22,762
2020		91,896
2020 (remaining)				$	68,993
2021		93,593			93,593
2022		95,006			95,006
Total operating lease payments, undiscounted	$	303,257		$	257,592
Less: interest		(26,554	)		(29,985	)
Lease liability, at present value	$	276,703		$	227,607

Item 2: Management’s Discussion and Analysis of Financial Condition and Results of Operations

Texas Republic Capital Corporation (“we” “us”, “our”, “TRCC” or the “Company”) was incorporated in May 2012 as a financial services holding company. Between May 2012 and November 2013, we conducted an organizational offering and three private placements of our common stock. From the organizational offering and private placements, we raised $10,336,500, incurred $1,215,569 of offering costs and issued 12,865,000 shares of our common stock. During 2012, the funds raised, offering costs incurred and shares subscribed from the private placements were $5,051,300, $180,835 and 10,636,840, respectively. During 2013, the funds raised, offering costs incurred and shares subscribed from the private placements were $5,285,200, $1,034,734 and 2,228,160, respectively.

We began an intrastate public offering of our common stock at a price per share of $5.00 on April 2, 2014 and completed that offering on April 2, 2017. The Company raised $10,010,485 and incurred $1,444,127 of offering costs through the issuance of 2,002,097 shares of the Company’s common stock less treasury stock of 3,000 shares from the intrastate public stock offering. During 2014, the funds raised, offering costs incurred and shares subscribed from the offering were $3,143,800, $576,613 and 628,760, respectively. During 2015, the funds raised, offering costs incurred and shares subscribed from the offering were $1,901,925, $326,734 and 380,385, respectively. During 2016 the funds raised, offering costs incurred and shares subscribed from the offering were $3,062,510, $330,516 and 612,502, respectively. During 2017 the funds raised, offering costs incurred and shares subscribed from the offering were $1,902,250, $210,264 and 380,450, respectively.

The Texas Department of Insurance approved TRLIC’s life insurance charter on August 1, 2016. The Company capitalized TRLIC with $3,000,000 and owns 100% of TRLIC. TRLIC began insurance operations on April 3, 2017 and is currently selling life and annuity products in the state of Texas. During 2018 ~~TRCC~~the Company made capital contributions of $2,000,000 and $750,000 to TRLIC. During the second quarter of 2019 the Company made an additional capital contribution to TRLIC of mortgage loans valued at $857,133. During the third quarter of 2019 the Company made an additional capital contribution of $1,300,000 in cash to TRLIC bringing the total capitalization of TRLIC to $7,907,133. ~~Texas Republic Life Solutions (“TRLS”),~~TRLS, an insurance agency, was incorporated February 1, 2017. The Company capitalized TRLS with $50,000 and owns 100% of TRLS. During 2018 ~~TRCC~~the Company made aan additional capital contribution of $100,000 bringing the total capitalization of ~~TRLIC~~TRLS to $150,000.

We are a financial services holding company and have incurred significant net losses since our inception. As of ~~September 30, 2019,~~March 31, 2020, we had an accumulated deficit of ~~$6,651,501.~~$7,890,914. These losses have resulted from costs incurred while raising capital and start-up costs related to our insurance operations. We expect to continue to incur operating losses until we achieve a volume of inforce life insurance policies that provides premiums and investment income which are sufficient to cover our operating costs.

Our management’s discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements that have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses. On a continuing basis, we evaluate our estimates and assumptions.

We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. We believe the following accounting policies, judgments and estimates are the most critical to the preparation of our consolidated financial statements.

Fixed maturity securities are comprised of bonds that are classified as available-for-sale and are carried at fair value with unrealized gains and losses, net of applicable income taxes, reported in accumulated other comprehensive income. The amortized cost of fixed maturity securities available-for-sale is generally adjusted for amortization of premium and accretion of discount.

The Company evaluates the difference between the cost or amortized cost and estimated fair value of its investments to determine whether any decline in value is other-than-temporary in nature. This determination involves a degree of uncertainty. If a decline in the fair value of a security is determined to be temporary, the decline is recorded as an unrealized loss in ~~shareholders’~~stockholders’ equity. If a decline in a security’s fair value is considered to be other-than-temporary, the Company then determines the proper treatment for the other-than-temporary impairment. For fixed maturity securities available-for-sale, the amount of any other-than-temporary impairment related to a credit loss is recognized in earnings and reflected as a reduction in the cost basis of the security; and the amount of any other-than-temporary impairment related to other factors is recognized in other comprehensive income (loss) with no change to the cost basis of the security.

Likewise, if a change occurs in the Company’s intent to sell temporarily impaired securities prior to maturity or recovery in value, or if it becomes more likely than not that the Company will be required to sell such securities prior to recovery in value or maturity, a future impairment charge could result. If an other-than-temporary impairment related to a credit loss occurs with respect to a bond, the Company amortizes the reduced book value back to the security’s expected recovery value over the remaining term of the bond. The Company continues to review the security for further impairment that would prompt another write-down in the value.

Purchases and sales of securities are recorded on a trade-date basis. Interest earned on investments is recorded on the accrual basis and is included in net investment income.

The Company’s mortgage loan portfolio is comprised of residential properties with loan to appraised value ratios ~~at or~~ below ~~91%~~90%. Mortgage loans are carried at current book value. The fair values for mortgage loans are estimated using discounted cash flow analyses. For residential mortgage loans, the discount rate used was indexed to the LIBOR yield curve adjusted for an appropriate credit spread.

Costs that relate to and vary with the successful production of new business are deferred over life of the policy. Deferred acquisition costs, (DAC), consist of commissions and policy issuance, underwriting and agency expenses. DAC expenses are amortized primarily over the premium-paying period of life policies and as profits emerge on the annuity products, using the same assumptions as were used in computing liabilities for future policy benefits.

Sales inducement costs (SIC) are related to policy bonuses issued on some of the Company’s annuity products. SIC is deferred at the issuance of the policy and amortized over the ~~shorter of the~~ bonus period ~~or the life of the policy based~~ on ~~the expected future profits of the business.~~a straight-line basis. The amount deferred is based on the difference between the fund value with the bonus and the fund value without the bonus.

We evaluate our deferred income tax assets, which partially offset our deferred tax liabilities, for any necessary valuation allowances. In doing so, we consider our ability and potential for recovering income taxes associated with such assets, which involve significant judgment. Revisions to the assumptions associated with any necessary valuation allowances would be recognized in the financial statements in the period in which such revisions are made.

Results of Operations – Three ~~and~~ ~~Nine~~Months Ended ~~September~~ ~~30,~~March 31, 2020 and 2019 ~~and 2018~~

Our revenues are from the initial sales of insurance products and investment income from investments in fixed maturity available-for-sale securities, ~~mortgages~~mortgage loans and other long-term assets. Revenue included ~~$303,002~~$119,145 from ~~the sale~~sales of life insurance for the ~~nine~~three months ended ~~September 30, 2019 and $313,098~~March 31, 2020 compared to $118,392 from sales of life insurance for ~~the nine months ended September 30, 2018. For~~ the three months ended ~~September 30, the sale of life insurance generated revenue of $52,080 in 2019 and $77,341 in 2018.~~March 31, 2019. The Company also accepted annuity deposits of ~~$10,126,300~~$4,667,563 in ~~the nine months ended September 30, 2019 compared to annuity deposits of $1,710,579 for the nine months ended September 30, 2018. For~~ the three months ~~ending September 30, 2019 the Company accepted annuity deposits of $4,457,421. For~~ended March 31, 2020 compared to $2,567,302 in the three months ~~ending September 30, 2018 the Company accepted annuity~~ended March 31, 2019. Annuity deposits ~~of $393,768. Annuity deposits~~will generate revenue on investments but are not classified as revenue for GAAP reporting.

Investment income was ~~$513,125~~$216,976 for ~~the nine months ended September 30, 2019, an increase of $263,277 from $249,848 for the nine months ended September 30, 2018. For~~ the three months ~~ended September 30, 2019 investment income was $202,907 an increase of $88,941 over the $113,966~~ending March 31, 2020 compared to $136,571 for the three months ended ~~September 30, 2018. During 2019 the~~March 31, 2019. The Company ~~invested~~continues to invest in mortgage loans on real estate, lottery bonds and corporate bonds to increase investment yields to support interest expense on our annuity deposits. The Company also moved all non-operating cash to interest bearing money market accounts. Total revenues were $344,374 for the three months ended March 31, 2020, an increase of $85,878 from $258,496 for the three months ended March 31, 2019.

Our expenses relate to operating a financial services holding company, a life insurance company and an insurance agency.

Expenses were ~~$2,204,826 for the nine months ended September 30, 2019, an increase of $711,302 from $1,493,524 for the nine months ended September 30, 2018. Expenses were $764,235~~$997,623 for the three months ended ~~September 30, 2019,~~March 31, 2020, an increase of ~~$306,241~~$362,209 from ~~$457,994~~$635,414 for three months ended ~~September 30, 2018.~~March 31, 2019.

Total Benefits and Claims – ~~Claims~~The increase to policyholder benefits and ~~benefit expenses were $332,290 and $213,612~~claims of $177,336 for ~~the nine months ended September 30, 2019 and 2018, respectively. For~~ the three months ended ~~September 30, 2019 and 2018 total benefit and claim expenses were $107,793 and $51,510, respectively. The~~March 31, 2020 is primarily due to the increase ~~is consistent with life renewals and the increased annuity sales compared~~in interest credited to ~~2018.~~policyholders of $180,119.

Commissions – Commission expense increased ~~$137,638~~$71,807 for the ~~nine~~three months ended ~~September 30, 2019 as compared to the nine months ended September 30, 2018.~~March 31, 2020. The increase is consistent with the increased ~~insurance~~annuity sales which were ~~$8,405,625~~$2,100,261 higher than ~~the nine months ended September 30, 2018. Commission expense increased $92,402 for~~ the three months ended ~~September 30, 2019 compared to 2018.~~March 31, 2019.

Salaries and Wages – Salary expense increased ~~$359,362~~$92,544 for ~~the nine months ended September 30, 2019 as compared to the nine months ended September 30, 2018. For~~ the three months ended ~~September 30, 2019 salary expense increased $124,444.~~March 31, 2020. The increase is due to the addition of staff in the ~~first~~last quarter of ~~2019 and the addition of salaried sales agents in the fourth quarter of 2018.~~2019. Additionally, increases to existing salaries added to the variance.

The net loss was ~~$1,274,149,~~$653,249, or ~~$(0.09)~~$(0.04) per common share issued and outstanding for the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 compared to a net loss of ~~$877,342,~~$376,918, or ~~$(0.06)~~$(0.03) per share, for the ~~nine~~three months ended ~~September 30, 2018. For the three months ending September 30, the net loss was $477,554 or $(0.03) per share in 2019 and $254,013 or $(0.02) per share in 2018.~~March 31, 2019. The increase in the net loss for the three ~~and nine~~ months ending ~~September 30, 2019,~~March 31, 2020, was primarily attributable to the increase in expenses described above. We expect our losses to continue in the near future as we incur increased costs to grow our life insurance business. The weighted average common shares outstanding were ~~14,814,895~~14,764,587 and ~~14,863,319 for the nine months ended September 30, 2019 and 2018, respectively. The weighted average common shares outstanding were 14,801,587 and 14,862,097~~14,841,764 for the three months ended ~~September 30,~~March 31, 2020 and 2019, ~~and 2018,~~ respectively.

Financial Position – As of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019

Total assets of the Company increased from ~~$15,732,993~~$30,285,566 as of December 31, ~~2018~~2019 to ~~$26,314,961~~$34,296,159 as of ~~September 30, 2019,~~March 31, 2020, an increase of ~~$10,581,968 or 67.3%.~~$4,010,593.

Cash increased ~~$4,815,930~~$2,637,095 due to ~~$10,126,300~~$4,667,563 in annuity ~~deposits~~sales during the ~~nine~~three months ended ~~September 30, 2019.~~March 31, 2020. We are investing to maximize yields to support the insurance ~~operations, however the~~operations. Annuity sales in 2019 and the first ~~nine~~three months of 2020 significantly outpaced our ability to secure quality investments. All non-operating cash is held in interest bearing accounts.

The Company did invest some annuity deposits in fixed maturity securities ~~mortgage loans~~ and other assets (lottery bonds). The increase in ~~mortgage loans and~~ lottery bonds of ~~$1,028,643 and $1,626,801~~$872,971 are directly related to annuity deposits in Texas Republic Life Insurance Company. The increase of ~~$1,931,645~~$538,391 in fixed maturity securities was due to purchases ~~as well as~~of $1,108,806 but somewhat offset by unrealized ~~gains on existing securities.~~losses of $568,340.

Policyholder liabilities include benefit reserves for both life and annuity policies, claim reserves, deposit funds and advance premiums. Policyholder liabilities increased ~~$11,030,371~~$5,221,226 at ~~September 30, 2019~~March 31, 2020 compared to December 31, ~~2018.~~2019. The increase is directly related to the increase of ~~the liability for~~ annuity deposits and to a lesser extent the increase of inforce life ~~insurance reserves.~~insurance.

Total shareholders’ equity of the Company decreased from ~~$12,028,873~~$10,672,815 as of December 31, ~~2018~~2019 to ~~$11,326,813~~$9,539,734 as of ~~September 30, 2019.~~March 31, 2020. The decrease is mainly due to the net loss from operations of ~~$1,274,149. Somewhat offsetting~~$653,249 and the ~~net loss was a favorable~~ change in unrealized ~~gains~~losses on fixed income securities ~~increasing equity by $603,264.~~of $568,340.

Since inception, our operations have been financed primarily through an organizational offering, three private placement offerings and an intrastate public stock offering. Through April 2, 2017, we received $20,346,985 from the sale of 14,867,097 shares and incurred offering costs of $2,659,696. During 2017 and 2016 we paid $5,000 and $10,000 for 1,000 and 2,000 shares of Company’s common stock that is held as treasury stock, respectively. During 2018 the Company’s subsidiary, TRLIC purchased 14,000 shares for distribution under its Stock Incentive Plan. During 2019 TRLIC purchased an additional ~~60,000~~97,000 shares for distribution under its Stock Incentive Plan. As of ~~September 30,~~December 31, 2019, TRLIC distributed 11,490 shares under its Stock Incentive Plan. The remaining ~~65,510~~99,510 shares held by TRLIC and the 3,000 shares held by TRCC total 102,510 shares. These shares are held as treasury shares in the consolidated financials. Our operations have not been profitable and have generated significant operating losses since we were incorporated in 2012.

We had cash and cash equivalents totaling ~~$11,327,582~~$17,845,572 and ~~$6,511,652~~$15,208,477 as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018,~~2019, respectively. The Company maintains cash and cash equivalents at multiple institutions. The Federal Deposit Insurance Corporation insures interest and non-interest-bearing accounts up to $250,000. Uninsured balances aggregate ~~$38,618~~$911,571 and ~~$534,014~~$2,312,416 as of ~~September 30, 2019~~March 31, 2020 and December 31, ~~2018~~2019 respectively. Other funds are invested in mutual funds that invest in U.S. government securities. We monitor the solvency of all financial institutions in which we have funds to minimize the exposure for loss. The Company has not experienced any losses in such accounts.

Capital provided from the public offering will provide a considerable amount of operating funds for current and future operations. The operations of TRLIC should provide ample cash flows from premium income and investment income to meet operating requirements. Life insurance contract liabilities are generally long term in nature and are generally paid from future cash flows.

We believe that our existing cash and cash equivalents will be sufficient to fund our anticipated operating expenses and capital ~~expenditures for at least 12 months.~~expenditures. We have based this estimate upon assumptions that may prove to be wrong and we could use our capital resources sooner than we currently expect. The growth of TRLIC and TRLS may require additional capital as ~~it continues~~they continue to grow. As discussed above, the Company capitalized TRLIC with $3,000,000 cash during the third quarter of 2016 and capitalized TRLS with $50,000 during the second quarter of 2018. During 2018 TRCC made capital contributions of $2,000,000 and $750,000 to TRLIC. During the second quarter of 2019 the Company made an additional capital contribution to TRLIC of mortgage loans valued at $857,133. During the third quarter of 2019 the Company made an additional capital contribution of $1,300,000 in cash to TRLIC bringing the total capitalization of TRLIC to $7,907,133. During 2018 TRCC made a capital contribution of $100,000 to TRLS bringing the total capitalization of TRLS to $150,000.

Certain statements contained herein are forward-looking statements. The forward-looking statements are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, and include estimates and assumptions related to economic, competitive and legislative developments. Forward-looking statements may be identified by words such as “expects,” “intends,” “anticipates,” “plans,” “believes,” “estimates,” “will” or words of similar meaning; and include, but are not limited to, statements regarding the outlook of our business and financial performance. These forward-looking statements are subject to change and uncertainty, which are, in many instances, beyond our control and have been made based upon our expectations and beliefs concerning future developments and their potential effect upon us.

There can be no assurance that future developments will be in accordance with our expectations, or that the effect of future developments on us will be as anticipated. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties. There are certain important factors that could cause actual results to differ, possibly materially, from expectations or estimates reflected in such forward-looking statements.

It is not our corporate policy to make specific projections relating to future earnings, and we do not endorse any projections regarding future performance made by others. In addition, we do not publicly update or revise forward-looking statements based on the outcome of various foreseeable or unforeseeable developments.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer (“Certifying Officers”), has evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15(e) and 15d-15(e) of the Securities and Exchange Act of 1934 as amended (“Exchange Act”) as of the end of the fiscal period covered by this Quarterly Report on Form 10-Q. Based upon such evaluation, the Certifying Officers have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by us in the reports we file or submit under the Exchange Act is made known to management, including our Certifying Officers, as appropriate, to allow timely decisions regarding disclosure and that such information is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

There were no changes in the Company’s internal control over financial reporting during the ~~nine~~three months ended ~~September 30, 2019~~March 31, 2020 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

The Company sold 4,375,000 common shares at $.02 per share to its organizing shareholders in May of 2012 for total proceeds of $87,500. Subsequently, the Company completed three private placement stock offerings which raised $10,249,000 through the issuance of 8,490,000 shares from the private placement offerings in 2012 and 2013, including a private placement of 2,000,000 shares for $5,000,000 between February and November 2013. All of these shares were sold in reliance on the exemption from the registration requirements of the Securities Act of 1933 (the “1933 Act”) contained in Securities and Exchange Commission (“SEC”) Regulation D, Rule 506. No underwriter was involved in connection with the issuance of our shares, and we paid no finder’s fees in the private placements.

On April 2, 2014, the Company commenced an offering of 5,000,000 shares of common stock at $5.00 per share ($25,000,000 maximum) with a 10% over sale provision, in an intrastate public offering registered with the Texas State Securities Board. This offering was concluded on April 2, 2017 and was sold only to Texas residents pursuant to an exemption from the 1933 Act contained in Section 3(a)(11) of the 1933 Act and Rule 147 promulgated by the SEC. It was sold by issuer agents registered with the Texas State Securities Board. The Company raised $10,010,485 and paid commissions of $999,349 from the sale of 2,002,097 shares in this offering. ~~Proceeds have been used for working capital and the capitalization of a life insurance company and insurance agency.~~ Through ~~September 30, 2019~~March 31, 2020 the Company paid ~~$109,900~~$133,210 for ~~87,000~~114,000 shares of the Company’s common stock (treasury stock). Subsequently, 11,490 shares have been redistributed to agents under our stock incentive plan.

In accordance with requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Texas		45-5311713
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification Number)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common stock $0.01 par	-	None

Large accelerated filer ☐	Accelerated filer ☐	Non-accelerated filer ☐	Smaller reporting company ☒
Emerging growth company ☐

PART I. FINANCIAL INFORMATION		Page Number

Item 1. Consolidated Financial Statements

Consolidated Statements of Financial Position as of ~~September 30, 2019~~March 31, 2020 (Unaudited) and December 31, ~~2018~~2019		3

Consolidated Statements of Operations for the Three ~~and Nine~~ Months Ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~ (Unaudited)		4

Consolidated Statements of Comprehensive Loss for the Three ~~and Nine~~ Months Ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~ (Unaudited)		5

Consolidated Statements of Changes in Shareholders’ Equity for the Three ~~and Nine~~ Months Ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~ (Unaudited)		6

Consolidated Statements of Cash Flows for the ~~Nine~~Three Months Ended ~~September 30,~~March 31, 2020 and 2019 ~~and 2018~~ (Unaudited)		7

Notes to Consolidated Financial Statements (Unaudited)		8

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		2223

Item 4. Controls and Procedures		2728

Part II. OTHER INFORMATION

Item 1. Legal Proceedings		2829

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		2829

Item 3. Defaults upon Senior Securities		2829

Item 4. Mine Safety Disclosures		2829

Item 5. Other Information		2829

Item 6. Exhibits		2829

Signatures		2930

	Nine Months Ended September 30,
	2019			2018

Operating activities
Net loss	$	(1,274,149	)	$	(877,342	)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on investments		(82,806	)		(16,974	)
Provision for depreciation		9,253			7,456
Policy acquisition costs deferred		(305,757	)		(188,220	)
Policy acquisition costs amortized		54,130			53,956
Mortgage loan origination fees deferred		-			(9,565	)
Amortization of mortgage loan origination fees		946			64
Interest credited to policyholders		173,017			47,059
Non-cash salary expense		28,725			-
Change in assets and liabilities:
Accrued investment income		(27,710	)		(67,863	)
Due premium		(3,366	)		(18,991	)
Advances and notes receivable		(88,627	)		8,442
Security deposit		-			-
Prepaid and other assets		(51,353	)		(9,415	)
Future policy benefits		141,847			152,722
Policy claims		17,777			14,134
Other policy liabilities		238,145			(79,883	)
Accounts payable		(72,127	)		44,430
Net cash used in operating activities		(1,242,055	)		(939,990	)

Investing activities
Purchase of furniture and equipment		(5,033	)		-
Purchase of fixed maturity securities		(1,377,331	)		(4,074,752	)
Sales of fixed maturity securities		97,225			-
Purchase of mortgage loans		(1,065,934	)		(566,812	)
Payments on mortgage loans		37,954			3,761
Purchase of other long-term investments		(1,715,610	)		(251,000	)
Payments on other long-term investments		172,380			-
Net cash used in investing activities		(3,856,349	)		(4,888,803	)

Financing activities
Purchase of treasury stock		(59,900	)		(5,000	)
Policyholder deposits		10,126,300			1,710,579
Policyholder withdrawals		(146,941	)		(55,767	)
Deposit-type contracts - deposits		-			24,521
Deposit-type contracts - withdrawals		(5,125	)		(5,125	)
Net cash provided by financing activities		9,914,334			1,669,208

Increase (decrease) in cash and cash equivalents		4,815,930			(4,159,585	)
Cash and cash equivalents, beginning of period		6,511,652			12,578,650
Cash and cash equivalents, end of period	$	11,327,582		$	8,419,065

	Three Months Ended March 31,
	2020			2019

Operating activities
Net loss	$	(653,249	)	$	(376,918	)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on investments		(53,710	)		(12,038	)
Provision for depreciation		2,917			2,951
Policy acquisition costs deferred		(135,177	)		(91,949	)
Policy acquisition costs amortized		25,371			21,009
Amortization of mortgage loan origination fees		8,270			250
Interest credited to policyholders		206,151			26,032
Change in assets and liabilities:
Accrued investment income		(27,692	)		(12,791	)
Due premium		(13,450	)		(5,050	)
Advances and notes receivable		(42,261	)		(32,666	)
Federal and state income taxes recoverable		(18,043	)		(71,839	)
Prepaid and other assets		(33,739	)		82,077
Future policy benefits		56,377			59,358
Policy claims		2,421			2,239
Other policy liabilities		110,656			333,625
Accounts payable		30,243			8,810
Net cash used in operating activities		(534,915	)		(66,900	)

Investing activities
Purchase of furniture and equipment		-			(3,365	)
Purchase of fixed maturity securities		(1,108,806	)		(202,726	)
Payments on mortgage loans		436,387			10,130
Purchase of other long-term investments		(882,909	)		(297,998	)
Payments on other long-term investments		64,900			-
Net cash used in investing activities		(1,490,428	)		(493,959	)

Financing activities
Purchase of treasury stock		-			(50,000	)
Policyholder deposits		4,667,563			2,567,302
Policyholder withdrawals		-			(65,590	)
Deposit-type contracts - withdrawals		(5,125	)		(5,125	)
Net cash provided by financing activities		4,662,438			2,446,587

Increase in cash and cash equivalents		2,637,095			1,885,728
Cash and cash equivalents, beginning of period		15,208,477			6,511,652
Cash and cash equivalents, end of period	$	17,845,572		$	8,397,380

	March 31, 2020		%			December 31, 2019		%
California	$	291,056		10.3	%	$	137,888		7.0	%
Indiana		193,358		6.8			209,829		10.7
Massachusetts		1,008,952		35.6			408,037		20.8
New York		662,491		23.3			692,016		35.2
Ohio		165,047		5.8			161,073		8.2
Oregon		142,700		5.0			140,304		7.1
Pennsylvania		375,714		13.2			217,200		11.0
Total	$	2,839,318		100.0	%	$	1,966,347		100.0	%

State	March 31, 2020		%			December 31, 2019		%
Alabama	$	145,304		5.9	%	$	145,389		5.0	%
Florida		-		-			228,529		7.9
Illinois		582,424		23.6			782,437		26.9
Indiana		52,722		2.1			53,808		1.9
Missouri		54,622		2.2			55,857		1.9
Tennessee		769,981		31.3			780,840		26.8
Texas		714,174		29.0			715,931		24.6
Wisconsin		145,479		5.9			145,750		5.0
Total	$	2,464,706		100.0	%	$	2,908,541		100.0	%

	•		general economic conditions and financial factors, including the performance and fluctuations of fixed income, equity, real estate, credit capital and other financial markets;
	•		differences between actual experience regarding mortality, morbidity, persistency, surrenders, investment returns, and our pricing assumptions establishing liabilities and reserves or for other purposes;
	•		the effect of increased claims activity from natural or man-made catastrophes, pandemic disease, or other events resulting in catastrophic loss of life;
	•		inherent uncertainties in the determination of investment allowances and impairments and in the determination of the valuation allowance on the deferred income tax asset;
	•		investment losses and defaults;
	•		competition in our product lines;
	•		attraction and retention of qualified employees and agents;
	•		ineffectiveness of risk management policies and procedures in identifying, monitoring and managing risks;
	•		the availability, affordability and adequacy of reinsurance protection;
	•		the effects of emerging claim and coverage issues;
	•		the cyclical nature of the insurance business;
	•		interest rate fluctuations;
	•		changes in our experiences related to deferred policy acquisition costs;
	•		the ability and willingness of counterparties to our reinsurance arrangements and derivative instruments to pay balances due to us;
	•		rating agencies’ actions;
	•		domestic or international military actions;
	•		the effects of extensive government regulation of the insurance industry;
	•		changes in tax and securities law;
	•		changes in statutory or U.S. generally accepted accounting principles (“GAAP”), practices or policies;
	•		regulatory or legislative changes or developments;
	•		the effects of unanticipated events on our disaster recovery and business continuity planning;
	•		failures or limitations of our computer, data security and administration systems;
	•		risks of employee error or misconduct;
	•		the introduction of alternative healthcare solutions;
	•		the assimilation of life insurance businesses we acquire and the sound management of these businesses; and
	•		the availability of capital to expand our ~~business.~~business and
	•		Coronavirus Disease impact on the economic environment

31.1	Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer

31.2	Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer

32.1	Section 1350 Certification of Principal Executive Officer

32.2	Section 1350 Certification of Principal Financial Officer

101.INS**	XBRL Instance

101.SCH**	XBRL Taxonomy Extension Schema

101.CAL**	XBRL Taxonomy Extension Calculation

101.DEF**	XBRL Taxonomy Extension Definition

101.LAB**	XBRL Taxonomy Extension Labels

101.PRE**	XBRL Taxonomy Extension Presentation

	TEXAS REPUBLIC CAPITAL CORPORATION a Texas corporation

~~November 25, 2019~~June 24, 2020	By:	/s/ Timothy R. Miller
		Timothy R. Miller, President and Chief Executive Officer


~~November 25, 2019~~June 24, 2020	By:	/s/ Thomas F. Kopetic
		Thomas F. Kopetic, Chief Financial Officer